RedHill Biopharma met with the FDA to discuss its drug for irritable bowel syndrome with diarrhea, Bekinda, following a positive phase 2 study. 1. In a phase 2 study of 126 patients, Bekinda improved ...

Revenue-generating with an exciting, diversified, largely externally funded, advanced development pipeline and multiple upcoming catalysts. Recent highlights: Mr. Ben-Asher continued: "Having ...

RedHill Biopharma shares fell after a sharp rally as investors took profits, following updates on its GI drug aimed at easing GLP-1 treatment side effects and potential FDA approval paths.

Strong Use of Composition-of-Matter Coverage: Patent protects the molecular structure of RHB-107, providing market exclusivity beyond method-of-use claims COVID-19 Therapeutic Use: Includes coverage ...

RedHill Biopharma Ltd. (NASDAQ:RDHL) shares climbed 16.5% in premarket trading on Monday after the company reported advances in the development of RHB-102 (Bekinda), a therapy aimed at addressing ...

Haynes Boone represented RedHill Biopharma Ltd. in an appellate case, where the court affirmed a $6.5 million summary judgment in addition to interest and costs for RedHill. Simplicity won the day in ...

RedHill Biopharma (RDHL) announced that the New York Supreme Court’s summary judgment in favor of RedHill against Kukbo Co. is now final and eligible for enforcement and foreign recognition, with no ...

RedHill Biopharma says it’s getting good results in clinical trials using ondansetron pills to help alleviate side effects such as nausea, vomiting and diarrhea among people using the blockbuster ...

Under the terms of the agreement RedHill will receive $500,000 in guaranteed payments, including a $250,000 upfront payment and $250,000 in fixed payments due within 18 months, plus a minimum of $1.3 ...

RedHill Biopharma (RDHL) announced the coverage of Talicia by Humana’s Part D Plan, providing access to Talicia for H. pylori therapy to more than eight million additional Medicare lives, without the ...

The accompanying notes are an integral part of these condensed consolidated financial statements. [1] Including cash, cash equivalents, short-term bank deposits and restricted cash. [2] All financial ...

On October 16, 2025, the Company received a Staff Determination notification from The Nasdaq Stock Market LLC regarding continued non-compliance with the minimum stockholders' equity requirements for ...